183 related articles for article (PubMed ID: 8517334)
1. [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia.
Davis WK; Boyko OB; Hoffman JM; Hanson MW; Schold SC; Burger PC; Friedman AH; Coleman RE
AJNR Am J Neuroradiol; 1993; 14(3):515-23. PubMed ID: 8517334
[TBL] [Abstract][Full Text] [Related]
2. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
Gross MW; Weber WA; Feldmann HJ; Bartenstein P; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):989-95. PubMed ID: 9719107
[TBL] [Abstract][Full Text] [Related]
3. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
[TBL] [Abstract][Full Text] [Related]
4. Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.
Holodny AI; Makeyev S; Beattie BJ; Riad S; Blasberg RG
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1042-8. PubMed ID: 20150307
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Vlassenko AG; Thiessen B; Beattie BJ; Malkin MG; Blasberg RG
J Neurooncol; 2000; 46(3):249-59. PubMed ID: 10902856
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging of juvenile pilocytic astrocytomas: an enigma.
Fulham MJ; Melisi JW; Nishimiya J; Dwyer AJ; Di Chiro G
Radiology; 1993 Oct; 189(1):221-5. PubMed ID: 8372197
[TBL] [Abstract][Full Text] [Related]
7. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography.
Tovi M; Lilja A; Bergström M; Ericsson A; Bergström K; Hartman M
Acta Radiol; 1990 Sep; 31(5):417-29. PubMed ID: 2261284
[TBL] [Abstract][Full Text] [Related]
8. MR Gd-DTPA enhancement of radiation brain injury.
Nishimura R; Takahashi M; Morishita S; Sumi M; Uozumi H; Sakamoto Y
Radiat Med; 1992; 10(3):109-16. PubMed ID: 1509102
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
[TBL] [Abstract][Full Text] [Related]
10. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging.
Ohtani T; Kurihara H; Ishiuchi S; Saito N; Oriuchi N; Inoue T; Sasaki T
Eur J Nucl Med; 2001 Nov; 28(11):1664-70. PubMed ID: 11702108
[TBL] [Abstract][Full Text] [Related]
11. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
[TBL] [Abstract][Full Text] [Related]
13. Applying Amide Proton Transfer MR Imaging to Hybrid Brain PET/MR: Concordance with Gadolinium Enhancement and Added Value to [
Sun H; Xin J; Zhou J; Lu Z; Guo Q
Mol Imaging Biol; 2018 Jun; 20(3):473-481. PubMed ID: 29063304
[TBL] [Abstract][Full Text] [Related]
14. Alignment of volume MR images and high resolution [18F]fluorodeoxyglucose PET images for the evaluation of patients with brain tumors.
Nelson SJ; Day MR; Buffone PJ; Wald LL; Budinger TF; Hawkins R; Dillon WP; Huhn S; Prados MD; Chang S; Vigneron DB
J Comput Assist Tomogr; 1997; 21(2):183-91. PubMed ID: 9071283
[TBL] [Abstract][Full Text] [Related]
15. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
[TBL] [Abstract][Full Text] [Related]
16. Malignancy and viability of intraparenchymal brain tumours: correlation between Gd-DTPA contrast MR images and proliferative potentials.
Yoshii Y; Komatsu Y; Yamada T; Hyodo A; Nose T; Kobayashi E
Acta Neurochir (Wien); 1992; 117(3-4):187-94. PubMed ID: 1414520
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with routine Gd-DTPA administration for MR imaging of the brain.
Schwaighofer BW; Klein MV; Wesbey G; Hesselink JR
J Comput Assist Tomogr; 1990; 14(1):11-7. PubMed ID: 2298973
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging with gadolinium contrast agent in small deep (lacunar) cerebral infarcts.
Regli L; Regli F; Maeder P; Bogousslavsky J
Arch Neurol; 1993 Feb; 50(2):175-80. PubMed ID: 8431136
[TBL] [Abstract][Full Text] [Related]
19. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine.
Pirotte B; Goldman S; David P; Wikler D; Damhaut P; Vandesteene A; Salmon L; Brotchi J; Levivier M
Acta Neurochir Suppl; 1997; 68():133-8. PubMed ID: 9233429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
